Literature DB >> 8132829

Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood.

S O'Shea1, T Rostron, J E Mullen, J E Banatvala.   

Abstract

AIMS: To evaluate the stability of infectious HIV in clinical samples and the efficiency of isolating it from small volumes of whole blood.
METHODS: Titres of infectious HIV were measured in peripheral blood mononuclear cells and plasma 2, 24, and 48 hours after peripheral blood had been collected from 10 HIV positive adult volunteers. Volumes of whole blood (1 ml to 5 microliters), collected from a further five volunteers, were used to determine the minimum volume from which HIV could be isolated. Infectious HIV was isolated by co-culture with phytohaemagglutinin stimulated umbilical cord mononuclear cells.
RESULTS: Geometric mean titres of infectious HIV seemed to be more stable in peripheral blood mononuclear cells than in plasma. HIV was recovered from all 10 peripheral blood mononuclear cell samples during the 48 hours after sample collection, but from only four plasma samples. HIV could occasionally be isolated from 5 microliters of whole blood and reliably from 200 microliters.
CONCLUSIONS: HIV can be isolated from peripheral blood mononuclear cells and plasma for up to 48 hours after sample collection. Isolation of HIV from small volumes of whole blood has applications for the diagnosis and management, of HIV positive children.

Entities:  

Mesh:

Year:  1994        PMID: 8132829      PMCID: PMC501831          DOI: 10.1136/jcp.47.2.152

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Transmission of HIV-1 by component type and duration of shelf storage before transfusion.

Authors:  E Donegan; B A Lenes; P A Tomasulo; J W Mosley; J W Mosely
Journal:  Transfusion       Date:  1990 Nov-Dec       Impact factor: 3.157

2.  Postmortem viability of the human immunodeficiency virus.

Authors:  K Püschel; F Mohsenian; R Laufs; S Polywka; M Ermer
Journal:  Int J Legal Med       Date:  1991-03       Impact factor: 2.686

3.  Quantitation of HIV: correlation with clinical, virological, and immunological status.

Authors:  S O'Shea; T Rostron; A S Hamblin; S J Palmer; J E Banatvala
Journal:  J Med Virol       Date:  1991-09       Impact factor: 2.327

4.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments.

Authors:  L Resnick; K Veren; S Z Salahuddin; S Tondreau; P D Markham
Journal:  JAMA       Date:  1986-04-11       Impact factor: 56.272

5.  Cultivation of human immunodeficiency virus from whole blood: effect of anticoagulant and inoculum size on virus growth.

Authors:  G J Bayliss; W J Jesson; P P Mortimer; K A McLean; B A Evans
Journal:  J Med Virol       Date:  1990-06       Impact factor: 2.327

6.  Isolation of human immunodeficiency virus (HIV) at autopsy one to six days postmortem.

Authors:  M Nyberg; J Suni; M Haltia
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

7.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

8.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

9.  Infectious decay of human immunodeficiency virus type 1 in plasma.

Authors:  T Moudgil; E S Daar
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

  9 in total
  3 in total

1.  Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  L M Kirstein; J W Mellors; C R Rinaldo; J B Margolick; J V Giorgi; J P Phair; E Dietz; P Gupta; C H Sherlock; R Hogg; J S Montaner; A Muñoz
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  C C Ginocchio; X P Wang; M H Kaplan; G Mulligan; D Witt; J W Romano; M Cronin; R Carroll
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.

Authors:  M Holodniy; L Mole; B Yen-Lieberman; D Margolis; C Starkey; R Carroll; T Spahlinger; J Todd; J B Jackson
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.